Cargando…
Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy
Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocytur...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530666/ https://www.ncbi.nlm.nih.gov/pubmed/33004982 http://dx.doi.org/10.1038/s41598-020-73335-2 |
_version_ | 1783589612297388032 |
---|---|
author | Mella, Alberto Deambrosis, Ilaria Mingozzi, Silvia Colla, Loredana Burdese, Manuel Giaretta, Fulvia Bruno, Stefania Camussi, Giovanni Boaglio, Elena Dolla, Caterina Clari, Roberta Biancone, Luigi |
author_facet | Mella, Alberto Deambrosis, Ilaria Mingozzi, Silvia Colla, Loredana Burdese, Manuel Giaretta, Fulvia Bruno, Stefania Camussi, Giovanni Boaglio, Elena Dolla, Caterina Clari, Roberta Biancone, Luigi |
author_sort | Mella, Alberto |
collection | PubMed |
description | Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocyturia-PdoU). PdoU has been assessed in different kidney diseases, but limited data are available in iMN. In this study all patients with a diagnosis of iMN between 15/12/1999–16/07/2014 were tested for PLA(2)R antibodies (Ab anti-PLA(2)R, ELISA kit) and PdoU by flow cytometry with anti-podocalyxin antibody. A semi-quantitative PdoU score was defined according to the percentage of podocalyxin positive cells normalized to the total volume of sample and set relative to the urine creatinine measured in the supernatant. PdoU was positive in 17/27 patients (63%; 1+ score in 6/27—22.2%, 2+ in 4/27—14.8%, 3+ in 2/27—7.4%, 4+ in 5/27—18.5%). Only 2/7 patients with complete remission showed a positive PdoU (1+) while all six patients without remission have significant PdoU. PdoU+ was statistically correlated with the absence of remission and Ab anti-PLA(2)R + (p < 0.05) but PdoU, analysed as a continuous variable, showed a non-linear correlation with proteinuria or PLA(2)R antibody levels also in the cohort of patients with two available PdoU tests. In conclusion, PdoU could be detected in iMN and seems to be associated with commonly considered markers of disease activity (proteinuria and Ab anti-PLA(2)R) with a non-linear correlation. Despite data should be confirmed in large and prospective cohorts, according to the podocyte depletion hypothesis PdoU may represent an early marker of immunological activation with potential prognostic utility. |
format | Online Article Text |
id | pubmed-7530666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75306662020-10-02 Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy Mella, Alberto Deambrosis, Ilaria Mingozzi, Silvia Colla, Loredana Burdese, Manuel Giaretta, Fulvia Bruno, Stefania Camussi, Giovanni Boaglio, Elena Dolla, Caterina Clari, Roberta Biancone, Luigi Sci Rep Article Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocyturia-PdoU). PdoU has been assessed in different kidney diseases, but limited data are available in iMN. In this study all patients with a diagnosis of iMN between 15/12/1999–16/07/2014 were tested for PLA(2)R antibodies (Ab anti-PLA(2)R, ELISA kit) and PdoU by flow cytometry with anti-podocalyxin antibody. A semi-quantitative PdoU score was defined according to the percentage of podocalyxin positive cells normalized to the total volume of sample and set relative to the urine creatinine measured in the supernatant. PdoU was positive in 17/27 patients (63%; 1+ score in 6/27—22.2%, 2+ in 4/27—14.8%, 3+ in 2/27—7.4%, 4+ in 5/27—18.5%). Only 2/7 patients with complete remission showed a positive PdoU (1+) while all six patients without remission have significant PdoU. PdoU+ was statistically correlated with the absence of remission and Ab anti-PLA(2)R + (p < 0.05) but PdoU, analysed as a continuous variable, showed a non-linear correlation with proteinuria or PLA(2)R antibody levels also in the cohort of patients with two available PdoU tests. In conclusion, PdoU could be detected in iMN and seems to be associated with commonly considered markers of disease activity (proteinuria and Ab anti-PLA(2)R) with a non-linear correlation. Despite data should be confirmed in large and prospective cohorts, according to the podocyte depletion hypothesis PdoU may represent an early marker of immunological activation with potential prognostic utility. Nature Publishing Group UK 2020-10-01 /pmc/articles/PMC7530666/ /pubmed/33004982 http://dx.doi.org/10.1038/s41598-020-73335-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Mella, Alberto Deambrosis, Ilaria Mingozzi, Silvia Colla, Loredana Burdese, Manuel Giaretta, Fulvia Bruno, Stefania Camussi, Giovanni Boaglio, Elena Dolla, Caterina Clari, Roberta Biancone, Luigi Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy |
title | Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy |
title_full | Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy |
title_fullStr | Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy |
title_full_unstemmed | Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy |
title_short | Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy |
title_sort | detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530666/ https://www.ncbi.nlm.nih.gov/pubmed/33004982 http://dx.doi.org/10.1038/s41598-020-73335-2 |
work_keys_str_mv | AT mellaalberto detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT deambrosisilaria detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT mingozzisilvia detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT collaloredana detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT burdesemanuel detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT giarettafulvia detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT brunostefania detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT camussigiovanni detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT boaglioelena detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT dollacaterina detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT clariroberta detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy AT bianconeluigi detectionofurinarypodocytesbyflowcytometryinidiopathicmembranousnephropathy |